Abstract
In this study we describe a method to identify important genes that appear to be involved in the cytotoxic mechanisms of key molecular fragments (biophores) contained within the structures of anticancer compounds. The anticancer biophores were mined by the MULTICASE program by analyzing 60 datasets containing 3271 compounds tested against the NCI-60 human cancer cell lines. For each identified fragment, statistically relevant genes were found by relating the activity profiles of the molecules containing the fragment and the gene expression profiles of the different cell lines. Microarray gene expression data of 13111 genes was used in conjunction with the LeFE algorithm to accomplish this task. We have demonstrated that regression analysis can then predict the cytotoxic activity of a compound in cell lines outside of those included in the regression model, even if it belongs to a different cancer type provided that the expression levels of identified genes are known for the cell lines. It is hoped that identifying key genes within the context of specific substructures responsible for the cytotoxic activity of anticancer agents could offer a better handle for designing specialized drugs targeting specific tumors based on their genetic profile.
Keywords: NCI-60, MULTICASE, anti-cancer, chemogenomics, cancer genes
Current Computer-Aided Drug Design
Title: Finding Relevant Genes Involved in the Cytotoxicity Mechanisms of Anticancer Biophores
Volume: 5 Issue: 4
Author(s): Suman K. Chakravarti and Gilles Klopman
Affiliation:
Keywords: NCI-60, MULTICASE, anti-cancer, chemogenomics, cancer genes
Abstract: In this study we describe a method to identify important genes that appear to be involved in the cytotoxic mechanisms of key molecular fragments (biophores) contained within the structures of anticancer compounds. The anticancer biophores were mined by the MULTICASE program by analyzing 60 datasets containing 3271 compounds tested against the NCI-60 human cancer cell lines. For each identified fragment, statistically relevant genes were found by relating the activity profiles of the molecules containing the fragment and the gene expression profiles of the different cell lines. Microarray gene expression data of 13111 genes was used in conjunction with the LeFE algorithm to accomplish this task. We have demonstrated that regression analysis can then predict the cytotoxic activity of a compound in cell lines outside of those included in the regression model, even if it belongs to a different cancer type provided that the expression levels of identified genes are known for the cell lines. It is hoped that identifying key genes within the context of specific substructures responsible for the cytotoxic activity of anticancer agents could offer a better handle for designing specialized drugs targeting specific tumors based on their genetic profile.
Export Options
About this article
Cite this article as:
Chakravarti K. Suman and Klopman Gilles, Finding Relevant Genes Involved in the Cytotoxicity Mechanisms of Anticancer Biophores, Current Computer-Aided Drug Design 2009; 5 (4) . https://dx.doi.org/10.2174/157340909789577883
DOI https://dx.doi.org/10.2174/157340909789577883 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neutrophil Derived Microvesicles: Emerging Role of a Key Mediator to the Immune Response
Endocrine, Metabolic & Immune Disorders - Drug Targets Discovery of Novel HDAC Inhibitors by Structure-based Optimization of Cinnamic Hydroxamic Scaffold
Letters in Drug Design & Discovery Plant Coumestans: Recent Advances and Future Perspectives in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Angiogenesis and Hypoxia in Glioblastoma: A Focus on Cancer Stem Cells
CNS & Neurological Disorders - Drug Targets MicroRNA in Implant Dentistry: From Basic Science to Clinical Application
MicroRNA Sch-66336 (Sarasar®) and Other Benzocycloheptapyridyl Farnesyl Protein Transferase Inhibitors: Discovery, Biology and Clinical Observations
Current Topics in Medicinal Chemistry Preparation and Quality Control of <sup>111</sup>In-Plerixafor for Chemokine Receptor CXCR4
Recent Patents and Topics on Imaging (Discontinued) Natural Products Targeting EGFR Signaling Pathways as Potential Anticancer Drugs
Current Protein & Peptide Science Optical and Multimodal Peptide-Based Probes for In Vivo Molecular Imaging
Anti-Cancer Agents in Medicinal Chemistry An Integrative Systems Analysis of High-grade Glioma Cell Lines: TLRs, Wnt, BRCA1, Netrins, STXBP1 and MDH1 Provide Putative Molecular Targets for Therapeutic Intervention
Current Pharmacogenomics and Personalized Medicine The Roles of Histone Demethylase UTX and JMJD3 (KDM6B) in Cancers: Current Progress and Future Perspectives
Current Medicinal Chemistry Application of Metabolomics in Drug Discovery, Development and Theranostics
Current Metabolomics Post-Transcriptional and Post-translational Regulation of Central Carbon Metabolic Enzymes in Cancer
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Potential of Natural Compounds that Regulate the Activity of Protein Kinase C
Current Medicinal Chemistry Immunobiologic Agents in Dermatology
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Unveiling the Role of Nuclear Transport in Epithelial-to-Mesenchymal Transition
Current Cancer Drug Targets Application of Phage Display Technology to Cancer Research
Current Pharmaceutical Biotechnology Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging
Current Medicinal Chemistry Application of Reproductive Hormone Peptides for Tumor Targeting
Current Pharmaceutical Biotechnology Leuckart Synthesis and Pharmacological Assessment of Novel Acetamide Derivatives
Anti-Cancer Agents in Medicinal Chemistry